Genesis Clinical Laboratories entered the industry of Hospitals in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $20.000.000 to $49.9999.999. The NAICS classifies this business under the code 6215110, which describes it as a Hospitals. For further clarification, the SIC classifies this business under the code 8062 and described it as a Hospitals. The business provides service to the B2C market.
To acquire more information, please contact Sharon Wagner, Manager by calling (708) 484-3280 during business hours. You can also write to the business’ Single Location at 3231 Euclid Avenue # 3, Berwyn, Illinois IL 60402. You can also visit the company’s website at macneal.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Genesis Clinical Laboratories |
| Representative: | Sharon Wagner, Manager |
| Place of Business: | 3231 Euclid Avenue # 3, Berwyn, IL 60402 |
| Contact Number: | (708) 484-3280 |
| Website: | macneal.com |
| Type of Service: | Hospitals |
| SIC Number: | 8062 |
| NAICS Number: | 6215110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Income/Year: | $20.000.000 to $49.9999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Genesis Clinical Laboratories is a company operating from Cook, Illinois providing professional Hospitals and relevant B2C variables. It was founded in 0 and registered with the SIC code 8062 as Hospitals, and with the NAICS code 6215110 as Hospitals.
With a current employee count of 1 to 4, Genesis Clinical Laboratories has gone to report making $20.000.000 to $49.9999.999 per annum on its journey towards growth. This company invites you to contact its representative Sharon Wagner, Manager at (708) 484-3280 for related queries, or to locate its Single Location using the coordinates 41.83295,-87.7915.
The Single Location can also be found at the street address 3231 Euclid Avenue # 3 in Berwyn, Illinois 60402 and can be engaged online through the company website at macneal.com, the company Twitter , and Facebook page .